Stockreport

BioNTech SE (BNTX) Q4 2025 Earnings Call Highlights: Strategic Advances Amidst Revenue Challenges [Yahoo! Finance]

BioNTech SE - American Depositary Shares  (BNTX) 
PDF This article first appeared on GuruFocus Total Revenue: EUR2.9 billion for 2025. Cash and Equivalents: EUR17.2 billion at the end of 2025. R&D Expenses: Approxima [Read more]